Haruhiko Yagi

15.2k citations

226 papers · 12.1k indexed · 3 hit papers · h-index 53

Molecular Biology top 1%
Cancer Research top 0.2%
Immunology top 0.5%
Oncology top 1%
Organic Chemistry top 0.5%

Co-authors: Donald M. Jerina Allan H. Conney Wayne Levin D. M. JERINA Alexander W. Wood Jane M. Sayer Dhiren R. Thakker Richard L. Chang
Topics: Carcinogens and Genotoxicity Assessment (47 papers)DNA and Nucleic Acid Chemistry (44 papers)Pharmacogenetics and Drug Metabolism (32 papers)
Cited by: Cancer Research Pharmacology Immunology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Japan Switzerland

In The Last Decade

Haruhiko Yagi

220 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Foxp3⁺CD25⁺CD4⁺ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

2006 1.3k citations Haruhiko Yagi et al. profile →
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 ⁺ T lymphocytes are prognostic factors of human ovarian cancer

2007 1.2k citations Junzo Hamanishi, Masaki Mandai et al. Proceedings of the National Academy of Sciences profile →
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

2004 673 citations Haruhiko Yagi, Shingo Fujii et al. profile →

Peers

Countries citing papers authored by Haruhiko Yagi

Since Specialization

Citations

This map shows the geographic impact of Haruhiko Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Yagi more than expected).

Fields of papers citing papers by Haruhiko Yagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Yagi. The network helps show where Haruhiko Yagi may publish in the future.

Co-authorship network of co-authors of Haruhiko Yagi

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Yagi. A scholar is included among the top collaborators of Haruhiko Yagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Yagi. Haruhiko Yagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of p53 and p21WAF-1, apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development 2012 ·Medical Molecular Morphology ·Ayako Suzuki,Masatoshi Kariya,Noriomi Matsumura,Tsukasa Baba,Haruhiko Yagi,Masaki Mandai,Ikuo Konishi,Shingo Fujii	2
2	Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 ⁺ T lymphocytes are prognostic factors of human ovarian cancerbreakdown → 2007 ·Proceedings of the National Academy of Sciences ·Junzo Hamanishi,Masaki Mandai,Masashi Iwasaki,Taku Okazaki,Yoshimasa Tanaka,Ken Yamaguchi,Toshihiro Higuchi,Haruhiko Yagi,Kenji Takakura,Nagahiro Minato,Tasuku Honjo,Shingo Fujii	1155
3	Effect of DNA Modifications on DNA Processing by HIV-1 Integrase and Inhibitor Binding 2006 ·Journal of Biological Chemistry ·Allison A. Johnson,Jane M. Sayer,Haruhiko Yagi,(unknown),Françoise Debart,Martin A. Maier,David R. Corey,Jean‐Jacques Vasseur,Terrence R. Burke,Víctor E. Márquez,Donald M. Jerina,Yves Pommier	8
4	Position-specific Suppression and Enhancement of HIV-1 Integrase Reactions by Minor Groove Benzo[a]pyrene Diol Epoxide Deoxyguanine Adducts 2004 ·Journal of Biological Chemistry ·Allison A. Johnson,Jane M. Sayer,Haruhiko Yagi,(unknown),(unknown),Donald M. Jerina,Yves Pommier	4
5	r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in Human Urine 2003 ·Cancer Epidemiology and Prevention Biomarkers ·Stephen S. Hecht,Menglan Chen,Haruhiko Yagi,Donald M. Jerina,Steven G. Carmella	1
6	r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. 2003 ·PubMed ·Stephen S. Hecht,Menglan Chen,Haruhiko Yagi,Donald M. Jerina,Steven G. Carmella	60
7	SHORT COMMUNICATION: Benzo(c)phenanthrene 3, 4-dihydrodiol 1, 2-epoxide adducts in native and denatured DNA 1996 ·Carcinogenesis ·(unknown),Haruhiko Yagi,Donald M. Jerina,Anthony Dipple	5
8	NMR Solution Structure of a Nonanucleotide Duplex with a dG Mismatch Opposite a 10R Adduct Derived from Trans Addition of a Deoxyadenosine N6-Amino Group to (-)-(7S,8R,9R,10S)-7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene 1995 ·Biochemistry ·(unknown),Herman J. C. Yeh,Jane M. Sayer,Mahesh K. Lakshman,Haruhiko Yagi,Donald M. Jerina,David G. Gorenstein	43
9	Identification of individual benzo[c]phenanthrenedihydrodiol epoxide-DNA adducts by the phosphorus-32-postlabeling assay 1992 ·Chemical Research in Toxicology ·(unknown),Kimmo Peltonen,Haruhiko Yagi,D. M. Jerina,Anthony Dipple	7
10	High selectivity of polyclonal antibodies against DNA modified by diastereomeric benzo[a]phenanthrene-3,4-diol-1,2-epoxides 1992 ·Carcinogenesis ·Elizabeth R. Butch,(unknown),Kathryn Shaw,Teresa A. Smolarek,Ivo Schmerold,John N. Anderson,William M. Baird,Haruhiko Yagi,Donald M. Jerina	1
11	Stereoselective release of polycyclic aromatic hydrocarbon-deoxyadenosine adducts from DNA by the phosphorus-32 postlabeling and deoxyribonuclease I/snake venom phosphodiesterase digestion methods 1990 ·Chemical Research in Toxicology ·Albert M. Cheh,Haruhiko Yagi,Donald M. Jerina	17
12	Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes. 1982 ·Molecular Pharmacology ·Kamlesh P. Vyas,Wayne Levin,Haruhiko Yagi,Dhiren R. Thakker,Dene E. Ryan,P. E. Thomas,Allan H. Conney,D. M. JERINA	25
13	Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Jaime Kapitulnik,Peter G. Wislocki,Wayne Levin,Haruhiko Yagi,Donald M. Jerina,Allan H. Conney	210
14	Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Thomas J. Slaga,William M. Bracken,(unknown),Wayne Levin,Haruhiko Yagi,D. M. JERINA,Allan H. Conney	37
15	Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Wayne Levin,Alexander W. Wood,Richard L. Chang,Thomas J. Slaga,Haruhiko Yagi,D. M. Jerina,A. H. Conney	79
16	Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Thomas J. Slaga,William M. Bracken,Aurora Viaje,Wayne Levin,Haruhiko Yagi,D. M. JERINA,Allan H. Conney	70
17	High carcinogenicity of 2-hydroxybenzo(a)pyrene on mouse skin. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Peter G. Wislocki,Richard L. Chang,Alexander W. Wood,Wayne Levin,Haruhiko Yagi,Óscar Hernández,He Duck Mah,Patrick M. Dansette,Donald M. Jerina,Allan H. Conney	43
18	Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Wayne Levin,Alexander W. Wood,Peter G. Wislocki,Jaime Kapitulnik,Haruhiko Yagi,Donald M. Jerina,Allan H. Conney	60
19	Structural Requirements for the Metabolic Activation of Benzo[a]pyrene to Mutagenic Products: Effects of Modifications in the 4,5-, 7,8-, and 9,10-Positions 1977 ·Molecular Pharmacology ·Alexander W. Wood,Wayne Levin,Albert Lu,D. W. Ryan,S.B. West,Haruhiko Yagi,He Duck Mah,D. M. JERINA,Allan H. Conney	21
20	Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown),(unknown),(unknown),Wayne Levin,Haruhiko Yagi,Óscar Hernández,Patrick M. Dansette,(unknown),Conney Ah	138

About Haruhiko Yagi

Haruhiko Yagi is a scholar working on Pharmacology, Biochemistry and Cancer Research, having authored 226 papers that have together received 12.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (47 papers), DNA and Nucleic Acid Chemistry (44 papers) and Pharmacogenetics and Drug Metabolism (32 papers). The work is most often cited by research in Cancer Research (3.6k citations), Pharmacology (1.9k citations) and Immunology (2.6k citations). Haruhiko Yagi has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Donald M. Jerina, Allan H. Conney, Wayne Levin, D. M. JERINA, Alexander W. Wood, Jane M. Sayer, Dhiren R. Thakker, Richard L. Chang, Shimon Sakaguchi and Takashi Nomura. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact